Abstract:Genome targeting of restriction enzymes and DNA methyltransferases has many important applications including genome and epigenome editing. 15-20 years ago, my group was involved in the development of approaches for programmable genome targeting, aiming to connect enzymes with an oligodeoxynucleotide (ODN), which could form a sequence-specific triple helix at the genomic target site. Importantly, the target site of such enzyme-ODN conjugate could be varied simply by altering the ODN sequence promising great applicative values. However, this approach was facing many problems including the preparation and purification of the enzyme-ODN conjugates, their efficient delivery into cells, slow kinetics of triple helix formation and the requirement of a poly-purine target site sequence. Hence, for several years genome and epigenome editing approaches mainly were based on Zinc fingers and TAL proteins as targeting devices. More recently, CRISPR/Cas systems were discovered, which use a bound RNA for genome targeting that forms an RNA/DNA duplex with one DNA strand of the target site. These systems combine all potential advantages of the once imagined enzyme-ODN conjugates and avoid all main disadvantageous. Consequently, the application of CRISPR/Cas in genome and epigenome editing has exploded in recent years. We can draw two important conclusions from this example of research history. First, evolution still is the better bioengineer than humans and, whenever tested in parallel, natural solutions outcompete engineered ones. Second, CRISPR/Cas system were discovered in pure, curiosity driven, basic research, highlighting that it is basic, bottom-up research paving the way for fundamental innovation.

Primer and interviews: advances in targeted gene modification. Interview by Julie C. Kiefer.

[Applications of ZFN, TALEN and CRISPR/Cas9 Techniques in Disease Modeling and Gene Therapy].

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.

Various applications of TALEN- and CRISPR/Cas9-mediated homologous recombination to modify the Drosophila genome.

Genome Editing of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells with Zinc Finger Nucleases for Cellular Imaging.

Progress in zinc finger nuclease engineering for targeted genome modification]

[Advances in Genetic Modification Technologies].

[TALE Nuclease Engineering and Targeted Genome Modification].

Genome-Editing Technologies: Principles and Applications.

Gene targeting in the mouse: advances in introduction of transgenes into the genome by homologous recombination

Application of Zinc Finger Nucleases in Genome Targeting Modification

High-Efficiency And Heritable Gene Targeting In Mouse By Transcription Activator-Like Effector Nucleases

Recent advances in targeted genome engineering in mammalian systems.

Gene Editing's Sharp Edge: Understanding Zinc Finger Nucleases (ZFN), Transcription Activator-Like Effector Nucleases (TALEN) and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

Talen or Cas9-Rapid, Efficient and Specific Choices for Genome Modifications

Advances in Genome Editing Technology and Its Promising Application in Evolutionary and Ecological Studies.

Zinc-finger nucleases: a powerful tool for genetic engineering of animals

From Bioengineering to CRISPR/Cas9 - A Personal Retrospective of 20 Years of Research in Programmable Genome Targeting

Efficient and Specific Modifications of the Drosophila Genome by Means of an Easy TALEN Strategy

Reverse Genetic Approaches in Zebrafish